Jacksonville, United States
MMI - Medical Microinstruments, Inc. is a pioneering force in the field of robotic technology for soft tissue open surgery at the micro level. Founded in 2015 and headquartered in the United States, the company is revolutionizing the surgical landscape by enabling surgeons to explore advanced treatment options for intricate anatomical structures.
The heart of their innovation lies in the Symani® Surgical System, the first-ever commercially available platform that allows for microsurgical precision. This state-of-the-art system stands out by incorporating the world's smallest wristed instruments, along with tremor-reducing and motion-scaling technologies, making it feasible to conduct complex procedures with unprecedented precision.
In a significant milestone, MMI secured a $110.00M Series C investment on February 21, 2024, backed by prominent investors including RA Capital Management, Wellington Partners, and Andera Partner. With support from other major investment bodies, MMI is well-positioned to expand its groundbreaking contributions across various medical specialties.
